TEST RAPID ANTIGEN COVID-19 ( SARS-COV-2 ) nazal / nazofaringian - R 15915/02.09.2021
DA28695333 · published 2021-09-06 · completed 2021-09-06 · from Canori Systems (Bucuresti)
2,350 leiawarded value
2,350 leiestimated value
33124130-5CPV code
The quantity is not published in the open data. The MS/SEAP export has only the title and value; quantity and unit price appear only in the purchase's SICAP record, which you can look up on e-licitatie.ro.
The text does mention: 25 buc, 25 buc, 25 buc (read automatically from title/description; check the text below).
Description from SEAP
TEST RAPID ANTIGEN COVID 19 ( SARS-COV-2 ) Depisteaza si varianta Delta. Determinare : nazal / nazofaringian Toate componentele sunt individuale. Casete de testare -25 buc, Tampoane de recoltare sterile-25 buc, Tuburi de extractie ce contin solutia de tratare a probei, gata dozata -25 buc. Prezentare: 25 teste / kit Timp de citire :15 min Instructiuni de lucru in limba romana Caracteristici de Perfomanta comparatie cu RT-PCR ( CT<30) Rezultatul nazofaringian al Testului antigen fluorecare® SARS-CoV-2: sensibilitatea clinică 98.62%, specificitatea clinică 100%. Rezultatul nazal al Testului antigen fluorecare® SARS-CoV-2: sensibilitatea clinică 94.58%, specificitatea clinică de 100%. Producator: Shenzhen Microprofit Biotech (cod 1967) Certificari: Test recunoscut in Comunitatea Europeana, MARCAJ CE, AVIZ ANMDMR